Environmental health impacts: Occurrence, exposure and significance, Lancaster University, UK, 9-10 September 2003

Mutagenesis

Volumn 19, Issue 5, 2004, Pages 423-429

  Martin, Francis L ^a   Semple, Kirk T ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUTATHIONE TRANSFERASE; HEXACHLOROCYCLOHEXANE; ORGANOCHLORINE DERIVATIVE; POLYBROMINATED BIPHENYL; RALOXIFENE; TAMOXIFEN;

CARCINOGENICITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTAMINATION; DISEASE PREDISPOSITION; DNA DAMAGE; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GENOTOXICITY; HORMONE SYNTHESIS; HUMAN; MOLECULAR GENETICS; NONHUMAN; ORGANIC POLLUTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOXICITY TESTING; UNITED KINGDOM;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; HUMANS; MUTAGENS; MUTATION; NEOPLASMS; RISK;

EID: 6944250269     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/geh046     Document Type: Conference Paper

References (65)

1. Alcock,R.E., Sweetman,A.J., Juan,C.Y. and Jones,K.C. (2000) A generic model of human lifetime exposure to persistent organic contaminants: development and application to PCB-101. Environ. Pollut. 110, 253-265.
2. Ames,B.N. (1989) Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ. Mol. Mutagen., 14 (suppl. 16), 66-77.
3. Ashby,J., Tinwell,H., Odum,J. and Lefevre,P. (2004) Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities. Environ. Health Perspect., 112, 847-853.
4. Behnisch,P.A., Hosoe,K. and Sakai,S. (2001a) Bioanalytical screening methods for dioxins and dioxin-like compounds a review of bioassay/biomarker technology. Environ. Int., 27, 413-439.
5. Behnisch,P.A., Hosoe,K. and Sakai,S. (2001b) Combinatorial bio/chemical analysis of dioxin and dioxin-like compounds in waste recycling, feed/food, humans/wildlife and the environment. Environ. Int., 27, 495-519.
6. Benhamou,S., Laplanche,A., Guillonneau,B., Mejean,A., Desgrandchamps,F., Schrameck,C., Degieux,V. and Perin,F. (2003) DNA adducts in normal bladder tissue and bladder cancer risk. Mutagenesis 18, 445-448.
7. Bennett,W.P., Alavanja,M.C., Blomeke,B. et al. (1999) Environmental tobacco smoke, genetic susceptibility and risk of lung cancer in never-smoking women. J. Natl Cancer Inst., 23, 2009-2014.
8. Butkiewicz,D., Cole,K.J., Phillips,D.H., Harris,C.C. and Chorazy,M. (1999) GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur. J. Cancer Prev., 8 315-323.
9. Cahill,P.A., Knight,A.W., Billinton,N., Barker,M.G., Walsh,L., Keenan,P.O., Williams,C.V., Tweats,D.J. and Walmsley,RM. (2004) The GreenScreen genotoxicity assay: a screening validation programme. Mutagenesis, 19, 105-119.
10. Carmichael,P.L., Ugwumadu,A.H., Neven,P., Hewer,A.J., Poon,G.K. and Phillips,D.H. (1996) Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res., 56, 1475-1479.
11. 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium. Carcinogenesis, 20, 339-342.
12. Carmichael,P.L., Pole,J.C. and Neven,P. (2000) Modulation of endometrial transforming growth factor beta (TGFbeta) by tamoxifen. Eur. J. Cancer, 36 (suppl. 4), S42-S43.
13. 1 arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival. Mutagenesis, 17, 431-438.
14. Grover,P.L. and Martin,F.L. (2002) The initiation of breast and prostate cancer. Carcinogenesis, 23, 1095-1102.
15. Harrad,S.J., Sewart,A.P., Alcock,R. et al. (1994) Polychlorinated biphenyls (PCBs) in the British environment: sinks, sources and temporal trends. Environ. Pollut., 85, 131-146.
16. Henderson,B.E. and Feigelson,H.S. (2000) Hormonal carcinogenesis. Carcinogenesis, 21, 427-433.
17. Hemminki,K., Rajaniemi,H., Lindahl,B. and Moberger,B. (1996) Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res., 56, 4374-4377.
18. Hofseth,L.J., Saito,S., Hussain,S.P. et al. (2003) Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl Acad. Sci. USA, 100, 143-148.
19. Hussain,S.P., Amstad,P., Raja,K. et al. (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res., 60, 3333-3337.
20. Hussain,S.P., Hofseth,L.J. and Harris,C.C. (2001) Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer, 34, S7-S15.
21. Hussain,S.P., Hofseth,L.J. and Harris,C.C. (2003) Radical causes of cancer. Nature Rev. Cancer, 3, 276-285.
22. International Agency for Research on Cancer (1996) IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 66. Some Pharmaceutical Drugs. IARC, Lyon, France.
23. Jaward,F.M., Farrar,N.J., Harner,T., Sweetman,A.J. and Jones,K.C. (2004) Passive air sampling of PCBs, PBDEs and organochlorine pesticides across Europe. Environ. Sci. Technol., 38, 34-41.
24. Juan,C.Y., Thomas,G.O., Sweetman,A.J. and Jones,K.C. (2002) An input-output balance study for PCBs in humans. Environ. Int., 28, 203-214.
25. Kalantzi,O.I., Alcock,R.E., Johnston,P.A., Santillo,D., Stringer,R.L., Thomas,G.O. and Jones,K.C. (2001) The global distribution of PCBs and organochlorine pesticides in butter. Environ. Sci. Technol., 35, 1013-1018.
26. Kalantzi,O.I., Hewitt,R., Ford,K.J. et al. (2004a) Low-dose induction of micronuclei by lindane. Carcinogenesis, 25 613-622. doi:10.1093/carcin/bgh048 (accessed 19 December 2003).
27. Kalantzi,O.I., Martin,F.L., Thomas,G.O., Alcock,R.E., Tang,H.R., Drury,S.C., Carmichael,P.L., Nicholson,J.K. and Jones,K.C. (2004b) Different levels of polybrominated diphenyl ethers (PBDEs) and chlorinated compounds in breast milk from two UK regions. Environ. Health Perspect., 112, 1085-1091. doi:10.1289/ehp.6991 (accessed 21 April 2004).
28. Langdon,C.J., Piearce,T.G., Black,S. and Semple,K.T. (1999) Resistance to arsenic-toxicity in a population of the earthworm Lumbricus rubellus. Soil Biol. Biochem., 31, 1963-1967.
29. Langdon,C.J., Piearce,T.G., Meharg,A.A. and Semple,K.T. (2001a) Survival and behaviour of the earthworms Lumbricus rubellus and Dendrodrilus rubidus from arsenate-contaminated and non-contaminated sites. Soil Biol. Biochem., 33, 1239-1244.
30. Langdon,C.J., Piearce,T.G., Meharg,A.A. and Semple,K.T. (2001b) Resistance of copper toxicity in populations of Lumbricus rubellus and Dendrodrilus rubidus from contaminated mine wastes. Environ. Toxicol. Chem., 20, 2336-2341.
31. Langdon,C.J., Meharg,A.A., Feldmann,J., Charnock,J., Farquhar,M., Piearce,T.G., Semple,K.T. and Cotter-Howells,J. (2002) Arsenic speciation in arsenate-resistant and non-resistant populations of the earthworm, Lumbricus rubellus. J. Environ. Monitor, 4, 603-608.
32. Langdon,C.J., Piearce,T.G., Feldmann,J., Semple,K.T. and Meharg,A.A. (2003a) Arsenic metabolism in the earthworms Lumbricus rubellus and Dendrodrilus rubidus. Environ. Toxicol. Chem., 22, 1302-1308.
33. Langdon,C.J., Piearce,T.G., Meharg,A.A. and Semple,K.T. (2003b) Inherited resistance to arsenate- but not copper-toxicity in a population of Lumbricus rubellus. Environ. Toxicol. Chem., 22 2344-2348.
34. Langdon,C.J., Piearce,T.G., Meharg,A.A. and Semple,K.T. (2003c) Interactions between earthworms and arsenic in the soil environment: a review. Environ. Pollut., 124, 361-373.
35. McLuckie,K.I., Gaskell,M., Farmer,P.B., Martin,E.A., Jones,G.D. and Routledge,M.N. (2004) Effects of the order of exposure to a binary mixture of mutagens on the induced mutation spectra in the supF gene. Mutagenesis, 19, 137-141.
36. Meijer,S.N., Ockenden,W.A., Sweetman,A., Breivik,K., Grimalt,J.O. and Jones,K.C. (2003) Global distribution and budget of PCBs and HCB in background surface soils: implications for sources and environmental processes. Environ. Sci. Technol., 37, 667-672.
37. Misl'anova,C., Healey,K., White,K.L., Smith,E.C., Hardie,L.J., Dusinska,M., Wild,C.P. and Routledge,M.N. (2003) Binary exposure of A549 cells to benzo[a]pyrene and UVC radiation yields enhanced DNA damage in the comet assay but no enhancement of 8-oxo-deoxyguanosine. Environ. Mol. Mutagen., 42, 228-230.
38. Montesano,R., Hainaut,P. and Wild,C.P. (1997) Hepatocellular carcinoma: from gene to public health. J. Natl Cancer Inst., 89 1844-1851.
39. Norén,K. and Meironyté,D. (2000) Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere, 40, 1111-1123.
40. Olivier,M., Hussain,S.P., Caron de Fromentel,C., Hainaut,P. and Harris,C.C. (2004) TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ., 157, 247-270.
41. Palli,D., Masala,G., Vineis,P. et al. (2003) Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults. Carcinogenesis, 24, 739-746.
42. Perera,F.P., Mooney,L.A., Stampfer,M. et al. (2002) Associations between carcinogen-DNA damage, glutathione S-transferase genotypes and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis, 23, 1641-1646.
43. Peto,R., Darby,S., Deo,H., Silcocks,P., Whitley,E. and Doll,R. (2000) Smoking, smoking cessation and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br. Med. J., 321, 323-329.
44. Phillips,D.H. (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis, 23, 1979-2004.
45. Phillips,D.H., Hewer,A., Scholefield,J.H. and Skinner,P. (2004) Smoking-related DNA adducts in anal epithelium. Mutat. Res., 560, 167-172.
46. Piearce,T.G., Langdon,C.J., Meharg,A.A. and Semple,K.T. (2002) Yellow earthworms: pigmentation as an indicator of metal resistance in contaminated mine spoil. Soil Biol. Biochem., 34 1833-1838.
47. Plummer,M., Herrero,R., Franceschi,S., Meijer,C.J., Snijders,P., Bosch,F.X., de Sanjose,S. and Munoz,N. (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control, 14, 805-814.
48. Poirier,M.C. and Schild,L.J. (2003) The genotoxicity of tamoxifen: extent and consequences, Kona, Hawaii, January 23, 2003. Mutagenesis, 18, 395-399.
49. Prevedouros,K., MacLeod,M., Jones,K.C. and Sweetman,A.J. (2004) Modelling the fate of persistent organic pollutants in Europe: parameterisation of a gridded distribution model. Environ. Pollut., 128, 251-261.
50. Ricketts,H.J., Morgan,A.J., Spurgeon,D.J. and Kille,P. (2004) Measurement of annetocin gene expression: a new reproductive biomarker in earthworm ecotoxicology. Ecotoxicol. Environ. Saf., 57, 4-10.
51. Routledge,M.N., McLuckie,K.I., Jones,G.D., Farmer,P.B. and Martin,E.A. (2001) Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations. Carcinogenesis, 22, 1231-1238.
52. Sanderson,J.T., Seinen,W., Giesy,J.P. and van den Berg,M. (2000) 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity? Toxicol. Sci., 54, 121-127.
53. Sanderson,J.T., Boerma,J., Lansbergen,G.W. and van den Berg,M. (2002) Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol., 182, 44-54.
54. Shibutani,S., Suzuki,N., Terashima.I., Sugarman,S.M., Grollman,A.P. and Pearl,M.L. (1999) Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen. Chem. Res. Toxicol., 12, 646-653.
55. Silva,E., Rajapakse,N. and Kortenkamp,A. (2002) Something from "nothing" - eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol., 36, 1751-1756.
56. Smith,C.C., Lynch,A.M. and Gooderham,N.J. (2003) Evaluating the genetic toxicology of DNA-based products using existing genetic toxicology assays. Mutagenesis, 18, 259-264.
57. Snyder,R.D., Pearl,G.S., Mandakas,G., Choy,W.N., Goodsaid,F. and Rosenblum,I.Y. (2004) Assessment of the sensitivity of the computational programs DEREK, TOPKAT and MCASE in the prediction of the genotoxicity of pharmaceutical molecules. Environ. Mol. Mutagen., 43, 143-158.
58. Sweetman,A.J., Alcock,R.E., Wittsiepe,J. and Jones,K.C. (2000) Human exposure to PCDD/Fs in the UK: the development of a modelling approach to give historical and future perspectives. Environ. Int., 26, 37-47.
59. Thomas,G.O., Sweetman,A.J. and Jones,K.C. (1999) Metabolism and body-burden of PCBs in lactating dairy cows. Chemosphere, 39 1533-1544.
60. Tinwell,H. and Ashby,J. (2004) Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens. Environ. Health Perspect., 112, 575-582.
61. van Duursen,M.B., Sanderson,J.T., van der Bruggen,M., van der Linden,J. and van den Berg,M. (2003) Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicol. Appl. Pharmacol., 190, 241-250.
62. Waddell,W.J., Crooks,N.H. and Carmichael,P.L. (2004) Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats. Toxicol. Sci., 79, 38-40.
63. Weihua,Z., Ekman,J., Almkvist,A., Saji,S., Wang,L., Warner,M. and Gustafsson,J.A. (2002) Involvement of androgen receptor in 17β-estradiol-induced cell proliferation in rat uterus. Biol. Reprod. 67, 616-623.
64. White,I.N., de Matteis,F., Davies,A., Smith,L.L., Crofton-Sleigh,C., Venitt,S., Hewer,A. and Phillips,D.H. (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells. Carcinogenesis, 13 2197-2203.
65. Yared,E., McMillan,T.J. and Martin,F.L. (2002) Genotoxic effects of oestrogens in breast cells as detected by the micronucleus assay and the Comet assay. Mutagenesis, 17, 345-352.